BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28390994)

  • 1. Carbohydrazones as new class of carbonic anhydrase inhibitors: Synthesis, kinetics, and ligand docking studies.
    Iqbal S; Saleem M; Azim MK; Taha M; Salar U; Khan KM; Perveen S; Choudhary MI
    Bioorg Chem; 2017 Jun; 72():89-101. PubMed ID: 28390994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II.
    Ekhteiari Salmas R; Mestanoglu M; Durdagi S; Sentürk M; Kaya AA; Kaya EÇ
    J Enzyme Inhib Med Chem; 2016; 31(1):31-7. PubMed ID: 25676327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophores Modeling in Terms of Prediction of Theoretical Physicochemical Properties and Verification by EXPERIMENTAL correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors.
    Amirkhanov V; Rauf A; Hadda TB; Ovchynnikov V; Trush V; Saleem M; Raza M; Rehman T; Zgou H; Shaheen U; Farghaly TA
    Mini Rev Med Chem; 2019; 19(12):1015-1027. PubMed ID: 30806314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.
    Zaib S; Saeed A; Stolte K; Flörke U; Shahid M; Iqbal J
    Eur J Med Chem; 2014 May; 78():140-50. PubMed ID: 24681391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
    Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis.
    Salmas RE; Senturk M; Yurtsever M; Durdagi S
    J Enzyme Inhib Med Chem; 2016; 31(3):425-33. PubMed ID: 25950196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
    Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.
    Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives.
    Vanjare BD; Choi NG; Eom YS; Raza H; Hassan M; Lee KH; Kim SJ
    Mol Divers; 2023 Feb; 27(1):193-208. PubMed ID: 35344136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Molecular Docking of New N-Acyl Hydrazones- Benzimidazole as hCA I and II Inhibitors.
    Küçükoğlu K; Çevik UA; Nadaroglu H; Celik I; Işık A; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Med Chem; 2023; 19(5):485-494. PubMed ID: 36567289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
    Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
    Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors.
    Zaraei SO; El-Gamal MI; Shafique Z; Amjad ST; Afridi S; Zaib S; Anbar HS; El-Gamal R; Iqbal J
    Bioorg Med Chem; 2019 Sep; 27(17):3889-3901. PubMed ID: 31345748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
    Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.